Suppr超能文献

关于经济评估中的溢出效应:定义、映射综述和研究议程。

On spillovers in economic evaluations: definition, mapping review and research agenda.

机构信息

Erasmus School of Health Policy & Management (ESHPM), Erasmus University Rotterdam, Rotterdam, The Netherlands.

Erasmus Centre for Health Economics Rotterdam (EsCHER), Erasmus University Rotterdam, Rotterdam, The Netherlands.

出版信息

Eur J Health Econ. 2024 Sep;25(7):1239-1260. doi: 10.1007/s10198-023-01658-8. Epub 2024 Jan 23.

Abstract

An important issue in economic evaluations is determining whether all relevant impacts are considered, given the perspective chosen for the analysis. Acknowledging that patients are not isolated individuals has important implications in this context. Increasingly, the term "spillovers" is used to label consequences of health interventions on others. However, a clear definition of spillovers is lacking, and as a result, the scope of the concept remains unclear. In this study, we aim to clarify the concept of spillovers by proposing a definition applicable in health economic evaluations. To illustrate the implications of this definition, we highlight the diversity of potential spillovers through an expanded impact inventory and conduct a mapping review that outlines the evidence base for the different types of spillovers. In the context of economic evaluations of health interventions, we define spillovers as all impacts from an intervention on all parties or entities other than the users of the intervention under evaluation. This definition encompasses a broader range of potential costs and effects, beyond informal caregivers and family members. The expanded impact inventory enables a systematic approach to identifying broader impacts of health interventions. The mapping review shows that the relevance of different types of spillovers is context-specific. Some spillovers are regularly included in economic evaluations, although not always recognised as such, while others are not. A consistent use of the term "spillovers", improved measurement of these costs and effects, and increased transparency in reporting them are still necessary. To that end, we propose a research agenda.

摘要

在经济评估中,一个重要的问题是,鉴于所选择的分析视角,是否考虑了所有相关的影响。承认患者不是孤立的个体,这在这种情况下具有重要意义。“溢出效应”一词越来越多地被用来描述卫生干预措施对他人的后果。然而,目前缺乏对溢出效应的明确定义,因此该概念的范围仍不清楚。在这项研究中,我们旨在通过提出一个适用于健康经济评估的定义来澄清溢出效应的概念。为了说明这一定义的含义,我们通过扩展影响清单突出了潜在溢出效应的多样性,并进行了映射审查,概述了不同类型溢出效应的证据基础。在卫生干预措施经济评估的背景下,我们将溢出效应定义为评估干预措施的使用者以外的所有各方或实体因干预措施而产生的所有影响。这个定义涵盖了更广泛的潜在成本和效果,超出了非正式照顾者和家庭成员的范围。扩展的影响清单使我们能够系统地识别卫生干预措施的更广泛影响。映射审查表明,不同类型溢出效应的相关性是特定于情境的。有些溢出效应经常被纳入经济评估中,尽管并不总是被认为是这样,而有些则没有。术语“溢出效应”的一致使用、对这些成本和效果的更好衡量以及在报告方面的透明度提高仍然是必要的。为此,我们提出了一个研究议程。

相似文献

1
On spillovers in economic evaluations: definition, mapping review and research agenda.
Eur J Health Econ. 2024 Sep;25(7):1239-1260. doi: 10.1007/s10198-023-01658-8. Epub 2024 Jan 23.
3
A Framework for Including Family Health Spillovers in Economic Evaluation.
Med Decis Making. 2016 Feb;36(2):176-86. doi: 10.1177/0272989X15605094. Epub 2015 Sep 16.
4
Analyzing the concept of spillover effects for expanded inclusion in health economics research.
J Comp Eff Res. 2020 Aug;9(11):755-766. doi: 10.2217/cer-2020-0051. Epub 2020 Jun 16.
5
Inclusion of Environmental Spillovers in Applied Economic Evaluations of Healthcare Products.
Value Health. 2023 Aug;26(8):1270-1281. doi: 10.1016/j.jval.2023.03.008. Epub 2023 Mar 24.
6
Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis.
Health Econ. 2016 Dec;25(12):1529-1544. doi: 10.1002/hec.3259. Epub 2015 Oct 14.
7
Incorporating Household Spillovers in Cost Utility Analysis: A Case Study Using Behavior Change in COPD.
Int J Technol Assess Health Care. 2019 Jan;35(3):212-220. doi: 10.1017/S026646231900028X. Epub 2019 May 8.
8
Addressing the distributional consequences of spillovers in health economic evaluation: A prioritarian approach.
Health Econ. 2024 Apr;33(4):764-778. doi: 10.1002/hec.4796. Epub 2024 Jan 7.
9
Toward a broader concept of societal value: family spillovers in Alzheimer's disease.
Int J Technol Assess Health Care. 2021 Dec 20;38(1):e7. doi: 10.1017/S0266462321000593.
10

引用本文的文献

1
Socioeconomic burden of cystic fibrosis in Canada.
BMJ Open Respir Res. 2024 Aug 9;11(1):e002309. doi: 10.1136/bmjresp-2024-002309.
2
Blockchain Applications in the Pharmaceutical Industry.
Blockchain Healthc Today. 2024 Apr 30;7. doi: 10.30953/bhty.v7.298. eCollection 2024.

本文引用的文献

1
Construct Validity, Reliability, and Responsiveness of the 10-Item Well-Being Instrument for Use in Economic Evaluation Studies.
Value Health. 2024 Jul;27(7):871-878. doi: 10.1016/j.jval.2024.02.014. Epub 2024 Mar 4.
2
Sibling spillovers and the choice to get vaccinated: Evidence from a regression discontinuity design.
J Health Econ. 2024 Mar;94:102843. doi: 10.1016/j.jhealeco.2023.102843. Epub 2023 Dec 27.
3
Inclusion of Environmental Spillovers in Applied Economic Evaluations of Healthcare Products.
Value Health. 2023 Aug;26(8):1270-1281. doi: 10.1016/j.jval.2023.03.008. Epub 2023 Mar 24.
4
Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects.
Pharmacoeconomics. 2023 Sep;41(9):1103-1115. doi: 10.1007/s40273-023-01253-y. Epub 2023 Mar 1.
6
Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations.
Pharmacoeconomics. 2022 Sep;40(9):837-850. doi: 10.1007/s40273-022-01164-4. Epub 2022 Jul 12.
9
A review of caregiver costs included in cost-of-illness studies.
Expert Rev Pharmacoecon Outcomes Res. 2022 Oct;22(7):1051-1060. doi: 10.1080/14737167.2022.2080056. Epub 2022 Jun 2.
10
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts.
Vaccine. 2022 Jun 26;40(30):3999-4007. doi: 10.1016/j.vaccine.2022.04.026. Epub 2022 May 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验